AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Japan · Delayed Price · Currency is JPY

870.00

+2.00 (0.23%)

Aug 12, 2026, 3:30 PM JST

-2.14% (1Y)

Market Cap	12.64B +1.1%
Revenue (ttm)	33.20B +1.9%
Net Income	1.20B -31.0%
EPS	83.81 -32.3%
Shares Out	14.56M
PE Ratio	10.36
Forward PE	n/a
Dividend	36.00 (4.15%)
Ex-Dividend Date	Aug 28, 2026

Volume	15,700
Open	870.00
Previous Close	868.00
Day's Range	868.00 - 872.00
52-Week Range	810.00 - 918.00
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 15, 2026

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs,... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1969

Employees 1,008

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2927

Full Company Profile

Financial Performance

In fiscal year 2025, AFC-HD AMS Life Science's revenue was 32.66 billion, an increase of 8.18% compared to the previous year's 30.19 billion. Earnings were 1.45 billion, an increase of 15.65%.

Financial Statements